Gene expression profiles of primary HPV16- and HPV18-infected early stage cervical cancers and normal cervical epithelium: Identification of novel candidate molecular markers for cervical cancer diagnosis and therapy

Virology

Volumn 331, Issue 2, 2005, Pages 269-291

  Santin, Alessandro D ^a,e   Zhan, Fenghuang ^a   Bignotti, Eliana ^a   Siegel, Eric R ^b   Cané, Stefania ^a   Bellone, Stefania ^a   Palmieri, Michela ^a   Anfossi, Simone ^a   Thomas, Maria ^b   Burnett, Alexander ^a   Kay, Helen H ^b   Roman, Juan J ^a   O'Brien, Timothy J ^a   Tian, Erming ^a   Cannon, Martin J ^c   Shaughnessy Jr , John ^a   Pecorelli, Sergio ^d  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c UNIVERSITY OF ARKANSAS AT LITTLE ROCK   (United States)

^d UNIVERSITY OF BRESCIA   (Italy)

^e UNIVERSITY OF ARKANSAS MEDICAL CENTER   (United States)

Author keywords

Cervical cancer; Gene expression profiling; Human papillomavirus

Indexed keywords

CADHERIN; CADHERIN 13; CD97 ANTIGEN; CYCLIN B1; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLIN DEPENDENT KINASE INHIBITOR 2A; DEOXYURIDINE TRIPHOSPHATE PYROPHOSPHATASE; DNA TOPOISOMERASE (ATP HYDROLYSING); FORKHEAD BOX M1 PROTEIN; MINICHROMOSOME MAINTENANCE PROTEIN; MINICHROMOSOME MAINTENANCE PROTEIN 2; MINICHROMOSOME MAINTENANCE PROTEIN 4; MINICHROMOSOME MAINTENANCE PROTEIN 5; MOLECULAR MARKER; OLIGONUCLEOTIDE; PROSTAGLANDIN E SYNTHASE; PROSTAGLANDIN SYNTHASE; PROTEASE INHIBITOR 3; PROTEIN MYB; PROTEIN P16; PROTEINASE INHIBITOR; SERINE PROTEINASE INHIBITOR; TOPOISOMERASE II ALPHA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR E2F1; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA1; UBIQUITIN CONJUGATING ENZYME; UBIQUITIN CONJUGATING ENZYME E2C; UNCLASSIFIED DRUG; VIRUS ANTIGEN;

ARTICLE; AVIAN LEUKOSIS ONCOVIRUS; CANCER CELL CULTURE; CANCER DIAGNOSIS; CANCER INVASION; CANCER STAGING; CANCER THERAPY; CELL CULTURE; CONTROLLED STUDY; DNA MICROARRAY; DOWN REGULATION; EMBEDDING; FLOW CYTOMETRY; GENE CLUSTER; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; MESODERM; ONCOGENE MYB; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; UPREGULATION; UTERINE CERVIX CARCINOMA; UTERINE CERVIX EPITHELIUM; VALIDATION PROCESS; VERRUCA VULGARIS; VIRUS CELL TRANSFORMATION;

CELLS, CULTURED; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PAPILLOMAVIRIDAE; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS;

AVES; CACTUS VIRUS X; HUMAN PAPILLOMAVIRUS;

EID: 19944427466     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virol.2004.09.045     Document Type: Article

References (50)

1. W. Alazawi, M. Pett, B. Arch, L. Scott, T. Freeman, M.A. Stanley, and N. Coleman Changes in cervical keratinocyte gene expression associated with integration of human papillomavirus 16 Cancer Res. 62 2002 6959 6965
2. T. Asano, T. An, J. Mayes, L.A. Zwelling, and E.S. Kleinerman Transfection of human topoisomerase II alpha into etoposide-resistant cells: transient increase in sensitivity followed by down-regulation of the endogenous gene Biochem. J. 319 1996 307 313
3. G. Aust, W. Eichler, S. Laue, I. Lehmann, N.E. Heldin, O. Lotz, W.A. Scherbaum, H. Dralle, and C. Hoang-Vu CD97: a dedifferentiation marker in human thyroid carcinomas Cancer Res. 57 1997 1798 1806
4. C.M. Balch, P.A. Dougherty, G.A. Cloud, and A.B. Tilden Prostaglandin E2-mediated suppression of cellular immunity in colon cancer patients Surgery 95 1984 71 77
5. J.M. Barletta, S. Rainier, and A.P. Feinberg Reversal of loss of imprinting in tumor cells by 5-aza-2′-deoxycytidine Cancer Res. 57 1997 48 50
6. U.G. Bhat, P. Raychaudhuri, and W.T. Beck Functional interaction between human topoisomerase IIalpha and retinoblastoma protein Proc. Natl. Acad. Sci. U.S.A. 96 1999 7859 7864
7. J. Bies, B. Hoffman, A. Amanullah, T. Giese, and L. Wolff B-Myb prevents growth arrest associated with terminal differentiation of monocytic cells Oncogene 12 1996 355 363
8. F.X. Bosch, A. Lorincz, N. Munoz, C.J. Meijer, and K.V. Shah The causal relation between human papillomavirus and cervical cancer J. Clin. Pathol. 55 2002 244 265
9. Y.E. Chang, and L.A. Laimins Microarray analysis identifies interferon-inducible genes and Stat-1 as major transcriptional targets of human papillomavirus type 31 J. Virol. 74 2000 4174 4182
10. Y. Chen, C. Miller, R. Mosher, X. Zhao, J. Deeds, M. Morrissey, B. Bryant, D. Yang, R. Meyer, F. Cronin, B.S. Gostout, K. Smith-McCune, and R. Schlegel Identification of cervical cancer markers by cDNA and tissue microarrays Cancer Res. 63 2003 1927 1935
11. K.L. Clark, E.D. Halay, E. Lai, and S.K. Burley Co-crystal structure of the HNF-3/fork head DNA-recognition motif resembles histone H5 Nature 364 1993 412 420
12. S. Douc-Rasy, M. Barrois, S. Fogel, J.C. Ahomadegbe, D. Stehelin, J. Coll, and G. Riou High incidence of loss of heterozygosity and abnormal imprinting of H19 and IGF2 genes in invasive cervical carcinomas. Uncoupling of H19 and IGF2 expression and biallelic hypomethylation of H19 Oncogene 12 1996 423 430
13. O.J. Finn Premalignant lesions as targets for cancer vaccines J. Exp. Med. 198 2003 1623 1626
14. D. Gibbons, F. Fogt, J. Kasznica, J. Holden, and S. Nikulasson Comparison of topoisomerase II alpha and MIB-1 expression in uterine cervical squamous lesions Mod. Path. 10 1997 409 413
15. J. Hamann, B. Vogel, G.M. van Schijndel, and R.A. van Lier The seven-span transmembrane receptor CD97 has a cellular ligand (CD55, DAF) J. Exp. Med. 184 1996 1185 1189
16. S. Houlbrook, C.M. Addison, S.L. Davies, J. Carmichael, I.J. Stratford, A.L. Harris, and I.D. Hickson Relationship between expression of topoisomerase II isoforms and intrinsic sensitivity to topoisomerase II inhibitors in breast cancer cell lines Br. J. Cancer 72 1995 1454 1461
17. M. Huang, M. Stolina, S. Sharma, J.T. Mao, L. Zhu, P.W. Miller, J. Wollman, H. Herschman, and S.M. Dubinett Non-small cell lung cancer cyclooxygenase-2-dependent regulation of cytokine balance in lymphocytes and macrophages: up-regulation of interleukin 10 and down-regulation of interleukin 12 production Cancer Res. 58 1998 1208 1216
18. L.H. Jaspars, W. Vos, G. Aust, R.A. Van Lier, and J. Hamann Tissue distribution of the human CD97 EGF-TM7 receptor Tissue Antigens 57 2001 325 331
19. A. Jemal, T. Murray, A. Samuels, A. Ghafoor, E. Ward, and M.J. Thun Cancer statistics CA Cancer J. Clin. 53 2003 5 26
20. M. Joaquin, and R.J. Watson Cell cycle regulation by the B-Myb transcription factor Cell. Mol. Life Sci. 60 2003 2389 2401
21. K.H. Kaestner, W. Knochel, and D.E. Martinez Unified nomenclature for the winged helix/forkhead transcription factors Genes Dev. 14 2000 142 146
22. T. Kaneko-Ishino, Y. Kuroiwa, N. Miyoshi, T. Kohda, R. Suzuki, M. Yokoyama, S. Viville, S.C. Barton, F. Ishino, and M.A. Surani Peg1/Mest imprinted gene on chromosome 6 identified by cDNA subtraction hybridization Nat. Genet. 11 1995 52 59
23. H. Kao, J.A. Marto, T.K. Hoffmann, J. Shabanowitz, S.D. Finkelstein, T.L. Whiteside, D.F. Hunt, and O.J. Finn Identification of cyclin B1 as a shared human epithelial tumor-associated antigen recognized by T cells J. Exp. Med. 194 2001 1313 1323
24. S.N. Khleif, J. DeGregori, C.L. Yee, G.A. Otterson, F.J. Kaye, J.R. Nevins, and P.M. Howley Inhibition of cyclin D-CDK4/CDK6 activity is associated with an E2F-mediated induction of cyclin kinase inhibitor activity Proc. Natl. Acad. Sci. U.S.A. 93 1996 4350 4354
25. R.W. King, P.K. Jackson, and M.W. Kirschner Mitosis in transition. Review Cell 79 1994 563 571
26. M. Kohda, H. Hoshiya, M. Katoh, I. Tanaka, R. Masuda, T. Takemura, M. Fujiwara, and M. Oshimura Frequent loss of imprinting of IGF2 and MEST in lung adenocarcinoma Mol. Carcinog. 31 2001 184 191
27. W. Korver, J. Roose, and H. Clevers The winged-helix transcription factor Trident is expressed in cycling cells Nucleic Acids Res. 25 1997 1715 1719
28. E.W. Lam, J.D. Morris, R. Davies, T. Crook, R.J. Watson, and K.H. Vousden HPV16 E7 oncoprotein deregulates B-myb expression: correlation with targeting of p107/E2F complexes EMBO J. 13 1994 871 878
29. F. Landoni, A. Maneo, A. Colombo, F. Placa, R. Milani, P. Perego, G. Favini, L. Ferri, and G. Mangioni Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer Lancet 350 1997 535 540
30. D. Lin, M. Fiscella, P.M. O'Connor, J. Jackman, M. Chen, L.L. Luo, A. Sala, S. Travali, E. Appella, and W.E. Mercer Constitutive expression of B-myb can bypass p53-induced Waf1/Cip1-mediated G1 arrest Proc. Natl. Acad. Sci. U.S.A. 91 1994 10079 10083
31. Murakami, M., Nakatani, Y., Tanioka, T., Kudo, I., 2002. Prostaglandin E synthase. Prostaglandins Other Lipid Mediators 68-69, 383-399.
32. N. Murphy, M. Ring, A.G. Killalea, V. Uhlmann, M. O'Donovan, F. Mulcahy, M. Turner, E. McGuinness, M. Griffin, C. Martin, O. Sheils, and J.J. O'Leary 16INK4A as a marker for cervical dyskaryosis: CIN and cGIN in cervical biopsies and ThinPrep smears J. Clin. Pathol. 56 2003 56 63
33. M. Nees, J.M. Geoghegan, T. Hyman, S. Frank, L. Miller, and C.D. Woodworth Papillomavirus type 16 oncogenes downregulate expression of interferon-responsive genes and upregulate proliferation-associated and NF-kappaB-responsive genes in cervical keratinocytes J. Virol. 75 2001 4283 4296
34. S.T. Oh, S. Kyo, and L.A. Laimins Telomerase activation by human papillomavirus type 16 E6 protein: induction of human telomerase reverse transcriptase expression through Myc and GC-rich Sp1 binding sites J. Virol. 75 2001 5559 5566
35. I.S. Pedersen, P.A. Dervan, D. Broderick, M. Harrison, N. Miller, E. Delany, D. O'Shea, P. Costello, A. McGoldrick, G. Keating, B. Tobin, T. Gorey, and A. McCann Frequent loss of imprinting of PEG1/MEST in invasive breast cancer Cancer Res. 59 1999 5449 5451
36. Y. Pommier Topoisomerase I and II in cancer chemotherapy: update and perspectives Cancer Chemother. Pharmacol. 32 1993 103 108
37. D.E. Quelle, F. Zindy, R.A. Ashmun, and C.J. Sherr Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest Cell 83 1995 993 1000
38. G. Raschella, A. Negroni, A. Sala, S. Pucci, A. Romeo, and B. Calabretta Requirement of b-myb function for survival and differentiative potential of human neuroblastoma cells J. Biol. Chem. 270 1995 8540 8545
39. M.E. Ross, X. Zhou, G. Song, S.A. Shurtleff, K. Girtman, W.K. Williams, H.C. Liu, R. Mahfouz, S.C. Raimondi, N. Lenny, A. Patel, and J.R. Downing Classification of pediatric acute lymphoblastic leukemia by gene expression profiling Blood 102 2003 2951 2959
40. I. Ruiz, A. Altaba, P. Sanchez, and N. Dahmane Gli and hedgehog in cancer: tumours, embryos and stem cells Nat. Rev., Cancer 2 2002 361 372
41. K.J. Sales, A.A. Katz, M. Davis, S. Hinz, R.P. Soeters, M.D. Hofmeyr, R.P. Millar, and H.N. Jabbour Cyclooxygenase-2 expression and prostaglandin E(2) synthesis are up-regulated in carcinomas of the cervix: a possible autocrine/paracrine regulation of neoplastic cell function via EP2/EP4 receptors J. Clin. Endocrinol. Metab. 86 2001 2243 2249
42. T. Sano, N. Masuda, T. Oyama, and T. Nakajima Overexpression of p16 and p14ARF is associated with human papillomavirus infection in cervical squamous cell carcinoma and dysplasia Pathol. Int. 52 2002 375 383
43. A.D. Santin, P.L. Hermonat, A. Ravaggi, M. Chiriva-Internati, D. Zhan, S. Pecorelli, G.P. Parham, and M.J. Cannon Induction of human papillomavirus- specific CD4(+) and CD8(+) lymphocytes by E7-pulsed autologous dendritic cells in patients with human papillomavirus type 16- and 18-positive cervical cancer J. Virol. 73 1999 5402 5410
44. A.D. Santin, S. Bellone, M. Gokden, M.J. Cannon, and G.P. Parham Vaccination with HPV-18 E7-pulsed dendritic cells in a patient with metastatic cervical cancer N. Engl. J. Med. 346 2002 1752 1753
45. E.R. Siegel, T. Spencer, and R.S. Parrish Controlling false discovery when planning microarray experiments 2003 Proceedings of the American Statistical Association 2004 Mira Digital Publishing St. Louis, MO 3897 3899
46. M.T. The, S.T. Wong, G.W. Neill, L.R. Ghali, M.P. Philpott, and A.G. Quinn FOXM1 is a downstream target of Gli1 in basal cell carcinomas Cancer Res. 62 2002 4773 4780
47. K.M. Yao, M. Sha, Z. Lu, and G.G. Wong Molecular analysis of a novel winged helix protein, WIN. Expression pattern, DNA binding property, and alternative splicing within the DNA binding domain J. Biol. Chem. 272 1997 19827 19836
48. H. Ye, T.F. Kelly, U. Samadani, L. Lim, S. Rubio, D.G. Overdier, K.A. Roebuck, and R.H. Costa Hepatocyte nuclear factor 3/fork head homolog 11 is expressed in proliferating epithelial and mesenchymal cells of embryonic and adult tissues Mol. Cell. Biol. 17 1997 1626 1641
49. M. Yu, Q. Zhan, and O.J. Finn Immune recognition of cyclin B1 as a tumor antigen is a result of its overexpression in human tumors that is caused by non-functional p53 Mol. Immunol. 38 2002 981 987
50. F. Zhan, E. Tian, K. Bumm, R. Smith, B. Barlogie, and J. Shaughnessy Jr. Gene expression profiling of human plasma cell differentiation and classification of multiple myeloma based on similarities to distinct stages of late-stage B-cell development Blood 99 2002 1745 1757